<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95751">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01883856</url>
  </required_header>
  <id_info>
    <org_study_id>16051</org_study_id>
    <nct_id>NCT01883856</nct_id>
  </id_info>
  <brief_title>Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves</brief_title>
  <official_title>Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New World Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the clinical outcomes after
      implantation of the porous plate (polyethylene) (Model M4) Ahmed Glaucoma Valve with the
      silicone plate Ahmed Glaucoma Valve (Model FP7) in participants with refractory glaucoma.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Intraocular Pressure</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary endpoint is the mean intraocular pressure in the porous plate group as compared to the silicone plate group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti-Glaucoma Medications</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The mean number of anti-glaucoma medications in the porous plate group as compared to the silicone plate group at 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Success</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Surgical success in the porous plate group as compared to the silicone plate group at 12 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Refractory Glaucoma</condition>
  <condition>Intractable Glaucoma</condition>
  <arm_group>
    <arm_group_label>Silicone Plate Ahmed Glaucoma Valve (Model FP7)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Silicone plate Ahmed Glaucoma Valve (Model FP7)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Porous Plate Ahmed Glaucoma Valve (Model M4)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Porous Plate Ahmed Glaucoma Valve (Model M4)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicone plate Ahmed Glaucoma Valve (Model FP7)</intervention_name>
    <arm_group_label>Silicone Plate Ahmed Glaucoma Valve (Model FP7)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Porous Plate Ahmed Glaucoma Valve (Model M4)</intervention_name>
    <arm_group_label>Porous Plate Ahmed Glaucoma Valve (Model M4)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female of any race ≥ 18 years and ≤  80 years of age.

          -  Diagnosis of intractable glaucoma in the study eye, with the exception of silicone
             oil endotamponade induced glaucoma, which has not responded to conventional medical
             and surgical therapy.

          -  Elevated intraocular pressure &gt; 21 mmHg in the study eye.  Two consecutive
             measurements using Goldmann Applanation Tonometry will be obtained and the mean of
             those two measurements will be considered the subject's baseline intraocular
             pressure.

          -  Subject is a candidate for surgery in the study eye with a glaucoma drainage device.

          -  Subject is willing and able to sign the informed consent.

        Exclusion Criteria:

          -  Diagnosis of silicone oil endotamponade induced glaucoma in the study eye.

          -  History of prior drainage implant surgery in the study eye.

          -  History of cyclophotocoagulation of the study eye.

          -  Pregnancy.

          -  Prisoner.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter A Netland, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peter A Netland, MD, PhD</last_name>
    <phone>(434) 243-2852</phone>
    <email>klh7v@virginia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristina Holbrook</last_name>
    <phone>(434) 243-2852</phone>
    <email>klh7v@virginia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Holbrook</last_name>
      <phone>434-243-2852</phone>
      <email>klh7v@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Peter A Netland, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 20, 2013</lastchanged_date>
  <firstreceived_date>June 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Refractory Glaucoma</keyword>
  <keyword>Intractable Glaucoma</keyword>
  <keyword>Primary Open Angle Glaucoma</keyword>
  <keyword>Neovascular Glaucoma</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
